As the need to draw awareness to cervical, ovarian, uterine/endometrial, vaginal, and vulvar cancer becomes more evident, ...

What is ovarian cancer? It's a cancer that strikes a woman's ovaries, the small almond-shaped organs that produce and release ...

Dr. Diego Aviles with UT Physicians says symptoms of ovarian cancer typically include bloating, pain in the stomach or pelvis ...

Researchers at the Wellcome Sanger Institute have identified over 3,000 genetic variants in the RAD51C gene that ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

New reserach has identified particular genetic mutations that elevate the risk of breast and ovarian cancers, aiding in ...

Researchers developed a pan-immune-inflammation–based nomogram to accurately predict overall survival (OS) and ...

Adding bevacizumab to the combination therapy of carboplatin and paclitaxel significantly improved progression-free survival ...

In a rough day for PARP inhibitors in ovarian cancer, GSK’s Zejula didn’t deliver a life extension benefit in the final ...

Researchers investigated RA51C and uncovered over 3,000 harmful genetic changes that could increase cancer risk.

Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer Brenetafusp is clinically active as monotherapy and in combination with ...